Merck & Co., Inc.



contact icon Contact Corporate Responsibility
survey icon Take our Survey
email icon E-mail a Friend/Colleague

Ethical Sales and Marketing Practices

Advancing the Dialogue Toward a Healthier Future


Overview Approach Performance Performance Priorities and Goals


Ethical Sales & Marketing Practices Performance Data Summary 2005-2008


2008 2007 2006 2005
 # warning letters or untitled letters from DDMAC* or APLB** in the U.S. 0 N/R N/R N/R

* DDMAC: U.S. U.S. FDA Division of Drug Marketing, Advertising and Communication
** APLB: Advertising and Promotional Labeling Branch ("APLB") of the FDA Center for Biologics Evaluation and Research

  • In 2008 Merck received no warning letters or untitled letters from the U.S. FDA Division of Drug Marketing, Advertising and Communication ("DDMAC") or from the Advertising and Promotional Labeling Branch ("APLB") of the FDA Center for Biologics Evaluation and Research.
  • In 2008, Merck implemented a more customer-centric selling model that is designed to provide a competitive advantage, help build trust with customers, and improve patient outcomes.
  • In 2008, to formalize our historical practice of informing health care professionals about our products before we advertise them to the consumer, Merck adopted a policy requiring a minimum six-month time period following the approval of a new product before launching DTC broadcast advertising in the US.
  • Since October 2008, Merck has been reporting grants over $500 provided by the Company's Global Human Health division to U.S. organizations in support of independent accredited educational programs for health care professionals. Over the course of 2009, Merck will expand this disclosure to include other grants. Merck will update these lists on a quarterly basis.
  • In 2009, Merck updated our sales and marketing policies and practices in the United States in compliance with the revised Pharmaceutical Research and Manufacturers of America (PhRMA) Code on Interactions with Healthcare Professionals.







    The content on this page was last modified on September 15, 2009.

    Merck & Co., Inc., Whitehouse Station, NJ, USA, and Schering-Plough Corporation, Kenilworth, NJ, USA, are now one company. We have combined our global operations under the name Merck & Co., Inc. We are working to update our corporate responsibility Web site to reflect our new, combined, global organization.

Printer Friendly Page
 

Quick Links


World Map of Key Activities  

External Links

 Copyright © 2009 Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Whitehouse Station, N.J., U.S.A.  Privacy  Terms of Use  Sitemap